- Detailed analysis of the pipeline for RA by stage of development, molecule type, program type, mechanism of action, and molecular target, as well as analysis of recent clinical trials by enrollment, duration, failure rate, and promising late-stage pipeline molecules
- Forecasts for the RA market, including epidemiology, treatment usage pattern, pricing, and market size for the 2013 – 2020 period, for which data are presented at country level with further analysis of key market drivers and barriers
- Major deals that have taken place in the global RA market since 2006, analyzing licensing and codevelopment agreements by stage of development, year, molecule type, mechanism of action and value; network graphs of these deals are also included
Reasons to buy
Primarily, the report will allow clients to gain a strong understanding of RA, helping to identify and clarify market opportunities and the competitive environment. It will also allow you to-
- Understand the RA pipeline and the key trends in the current product development landscape
- Observe detailed profiles for the promising pipeline products, including revenue forecasts, and gain an insight into how they are likely to compete in the market, and what their main competitors will be
Download sample Copy of This Report at: http:// www. radiantinsights. com / research / rheumatoid-arthritis-market-to-2020-acrowded-market-characterized-by-modest-growth / request-sample
- Follow the trends in RA clinical trial size and duration in relation to industry averages and assess the potential risk of future developmental programs for RA therapeutics, depending on the mechanism of action, by considering the recorded clinical trial failure rates
- Observe the potential growth patterns expected for the RA market over the forecast period, and identify which countries are expected to make the biggest contribution to this growth
Table of Contents 1 Table of Contents 4 1.1 List of Tables 7 1.2 List of Figures 7
Follow Us: